High quality of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

The vaccine is prepared from influenza virus type A and B prevalent strains recommended by WHO. The virus strains are inoculated in embryo eggs. After incubation, the virus liquid is harvested. The vaccine is prepared by inactivation, concentration, purification and splitting. The vaccine is a slightly opalescent liquid.

Active ingredients: Hemagglutinin of prevalent strains of influenza virus in current year. 0.5ml of the vaccine contains:

A/Guangdong-Maonan/SWL1536/2019(H1N1) pdm09-like virus…15μɡ HA

A/Hong Kong, S.A.R., China/2671/2019 (H3N2)-like virus……………………… 15μɡ HA

B/Washington/02/2019 (B/Victoria lineage)-like virus………………15μɡ HA

B/Phuket/3073/2013(B/Yamagata/16/88 lineage) -like virus………...15μɡ HA

Excipients: Na2HPO4, NaH2PO4, NaCl.

 [Vaccination Subjects]

The vaccine is approved for use in people aged 3 years old and above, especially in vulnerable people and high risk population for influenza complications, such as children, the elderly, the weak and people in influenza epidemic areas.

[Function and Use]

After vaccination, the vaccine can stimulate the body to produce the immunity of anti-influenza virus; it is used for preventing influenza caused by vaccine-related type of influenza virus.